The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and offering a wide range of dental certified courses in different formats.
Indian dental academy provides dental crown & Bridge,rotary endodontics,fixed orthodontics,
Dental implants courses.for details pls visit www.indiandentalacademy.com ,or call
0091-9248678078
4.16.24 21st Century Movements for Black Lives.pptx
Control Pain Anxiety Dental Procedures
1. CONTROL OF PAIN AND ANXIETY
INDIAN DENTAL ACADEMY
Leader in continuing dental education
www.indiandentalacademy.com
www.indiandentalacademy.com
2. PAIN
The international association for the study of pain
defines pain as “an unpleasant sensory and emotional
experience associated with actual or potential tissue damage
or describe in terms of such damage. “
www.indiandentalacademy.com
5. ANXIETY
It is an emotional state, unpleasant in nature,
associated with uneasiness, discomfort and concern of fear
about some defined or undefined future threat.
www.indiandentalacademy.com
6. Conscious Sedation
A state of mind obtained by IV administration
of
combination of anxiolytics, sedatives, and hypnotics and /or
analgesics that render the patient relaxed, yet allows the
patient to communicate, maintain patent airway and ventilate
adequately.
www.indiandentalacademy.com
8.
There have been remarkable advances in anesthesia and
surgical procedures as well as in dental surgery.
These milestones in dental and surgical treatment have
made it possible to perform procedures with greater
precision, predictability, speed and safety and often
without
pain.
However despite these advances a common problem that
still faces oral and maxillofacial surgeons is patients fear
and anxiety regarding the pain and discomfort associated
with their treatment.
www.indiandentalacademy.com
9. Therefore,
the
preoperative,
intraoperative
postoperative management of pain and anxiety is a
challenge faced by oral and maxillofacial
and
major
surgeons.
Research into the basic mechanisms of acute pain and
anxiety has led to a number of new strategies that have
yielded more precise and controlled forms of anesthesia.
-
More molecularly focused approach
-
Target specific receptor sites
www.indiandentalacademy.com
10.
This receptor oriented approach has allowed to move from
using only inhalation anesthetics or high dose barbiturates
for GA.
Safer alternatives and increasingly more specific agents
include,
-
Benzodiazepines
High potency synthetic opioids and propofol
Similarly new classes of analgesic drugs such as NSAIDS,
Cox-II inhibitors and opoid agonist – antagonists have
been developed in managing pain among out patients.
www.indiandentalacademy.com
11. GOALS OF THERAPY
Alleviate patients fear and anxiety
Sedate and calm patient intra operatively
Minimize spontaneous movements intraperatively
Alter patients recall (antegrade amnesia)
Maintain protective reflexes (conscious sedation)
Allow rapid and complete recovery in OP settings
Achieve safe and effective pain and anxiety control.
www.indiandentalacademy.com
12. Pre emptive / Preventive Strategies
Implementation of strategies to preempt or prevent the
pain resulting from surgical procedures or trauma that
provoke the release of inflammatory mediators, as well as
a cascade of pain inducing substances.
-
Long acting anesthetics
-
NSAID’S
-
Corticosteroids
www.indiandentalacademy.com
13.
Another preemptive strategy involves the preoperative
control of patients anxiety. In this regard, some clinicians
are using the technique of “pre programming” their
patients before surgery.
This technique effectively shapes
patient expectations, primes patients for effective pain
management and has the potential to reduce anxiety.
www.indiandentalacademy.com
15. Pharmacologic Agents used in Oral Maxillofacial
Surgery
Surgeons
are
increasingly
using
systemic
corticosteroids administered on a short term basis to control
facial edema and pain in patients having elective bony
surgery of the face. (JOMS 50 : 270, 1992)
www.indiandentalacademy.com
16. OPIOIDS
There is also a role for opioids in the prevention and
control of post operative pain. 3 classes of opioids currently
used.
1.
Single entity agonists (Meperidine or morphine)
administered by injection or orally. Because of dose
adverse effects, these drugs appear to have
OMFS.
www.indiandentalacademy.com
related
limited place in
17. 2.
The most widely prescribed type of opioids are those in
combination with other analgesic agents
Codeine, hydrocodone and oxycodone, in combination
with aspirin, acetaminophen or ibuprofen.
3.
The opioid agonist antagonists such as the intranasal
formulation of butorphanol also have been developed for
post operative pain.
www.indiandentalacademy.com
18. NSAID’S
NSAID’S are another class of analgesic commonly used
for mild to moderate pain. A related new class of drugs is the
COX-II inhibitors, which deliver pain relief with a significantly
lower risk of serious side effects common to chronic NSAID use
particularly.
-
Gastrointestinal perforation
-
Ulcers and
-
Bleeding
Although variety of newer analgesic agents are used for
the control of pain, LA’s, sedative hypnotics, and GA continue to
be widely used.
www.indiandentalacademy.com
19. Guidelines for Anxiety control & Pain management in OMFS
Pain and anxiety control involve the application of various
physical, chemical and psychologic modalities aimed at
preventing and treating preoperative, intraoperative, and post
operative patient anxiety and pain.
Organizations
Agencies
-
ADA
-
WHO
-
AAOMS
-
AHCPR
-
AAP
-
AAPD
-
APS
www.indiandentalacademy.com
20. The guidelines will be presented in 2 separate categories
-
Anxiety control
-
Pain control
However it should be noted that techniques focused on
one type of control often affect the other.
www.indiandentalacademy.com
21. Anxiety Control
ADA – has published 3 guidelines for the management of
pain and anxiety. ADA divides Pain & Anxiety control into 3
subcategories.
1.
Combined inhalation – enteral conscious sedation
2.
Parenteral conscious sedation and
3.
Combination of deep sedation and GA
www.indiandentalacademy.com
22. 1. Guidelines for Combined Inhalational enteral conscious
sedation are
a.
Patient evaluation (ASA classes I – IV)
b.
Preoperative or preanesthetic informed consent
c.
1 additional support person with or without BLS training
d.
Mandate monitoring by pulse oximetry and periodic
evaluation of vital signs.
www.indiandentalacademy.com
23. 2.
Parenteral Conscious Sedation
a.
1 additional support person who must have BLS training
b.
IV access should be established and maintained
c.
That a positive pressure O2 system be available
d.
Patients with CV disease be monitored by continuous
ECG.
www.indiandentalacademy.com
24. 3.
Deep Sedation and GA
a.
2 BLS trained person in addition to the surgeon
b.
Use of in line O2 analyzers and end tidal CO2 monitoring
– if not intubated, the patient may have either end tidal
CO2 or precordial stethoscope monitoring of respiratory
rate.
c.
Recording the body temperature and vitals signs are
taken every 5 minutes
www.indiandentalacademy.com
25. AAOMS
Have published guidelines for anesthesia divided into 3
categories.
1.
Conscious sedation is defined as minimally depressed
consciousness, anxiety and or pain.
This state is achieved while retaining an independent and
continuous airway and response to physical stimuli and verbal
commands
Full recovery in 12 hours.
www.indiandentalacademy.com
26. 2.
There are 3 criteria for determining the 2nd category –
Deep Sedation. Inability to respond to physical stimuli or verbal
commands, partial or complete loss of protective reflexes and
the absence of pain, anxiety, awareness and recall.
Recovery – 12 hours
3.
General Anesthesia
Inability to maintain the airway
www.indiandentalacademy.com
Recovery 12 hours.
27. AAPD
AAPD follows the guidelines of AAP.
Goals are to
achieve sedation levels 1 – 4 based on following functional
measures of sedation.
Level 1
-
Mild sedation (reduction of anxiety)
Level 2
-
Minimal depression with interaction possible
Level 3
-
Non interaction but arousal with mild to
moderate stimulus
Level 4
-
Non interaction and non arousal except with
intense stimulus
www.indiandentalacademy.com
28.
Facilitate quality care
Minimize disruptive behaviour
Promote positive psychologic response to treatment
Promote welfare and safety and
Return to a normal state of safe discharge
AAPD provides guidelines for preemptive anxiolytic
control by means of oral medication.
Preemptive control calls for the administration of minor
tranquilizers (hydroxyzin or benzodiazipines).
www.indiandentalacademy.com
30. Drugs commonly used for IV sedation, Sedative
hypnotic and anti-anxiety drugs
Benzadiazipines -
Diazepam, Midozolam
Barbiturates
Methahexitone
-
Non Barbiturate Drugs
Propofol
Ketamine
Neurolept analgesics
Anti-histamines
Promethazine
Narcotics
Pethidine, Pentazocine, Fentanyl
www.indiandentalacademy.com
31. Control of Post Operative Pain
Neither ADA nor the AAOMS have published specific
guidelines regarding management of acute post operative pain.
In 1990 WHO devised an “analgesic ladder”, a stepwise
approach to treat mild to severe pain.
Non opioid agents and possibly adjuvants should be used
for mild pain.
Opioids with non opioids and possibly adjuvants should
be used for mild to moderate pain.
Severe pain should be addressed with opioids and if
needed, non opioids and adjuvants.
www.indiandentalacademy.com
32. The APS adapted and simplified this “Analgesic Ladder”
by recommending that opioids be used when non opioids fail to
control pain.
The AHCPR published guidelines in 1992 that categorize
pain in to 2 levels.
-
Mild to moderate and
-
NSAID’S
-
Moderate to severe
-
OPIODS
www.indiandentalacademy.com
33. The AAOMS combined the guidelines of these three
agencies and also addressed 2 levels of post operative pain.
-
Mild to Moderate
-
NSAID’S and Low dose
Opioid / Non –Opioids
-
Moderate to Severe -
Opioids and Select
NSAID’S / Non-Opiods
www.indiandentalacademy.com
34. Drug Selection & Use
The APS, the AAOMS, and the AHCPR have evaluated
and recommended the use of non opioids, including
acetaminophen, salicylates / aspirin and NSAID’S for mild
pain.
Low dose opioids which include morphine like agonists
such as codeine, hydrocodone, oxycodone and mixed
agonist / antagonists (such as transnasal butorphanol)
are indicated for mild moderate pain.
Opioids for severe pain.
The ideal agent to treat moderate to severe pain
associated with OMFS should be potent and quick
acting.
www.indiandentalacademy.com
35. OPIODS RECOMMENDED FOR SEVERE PAIN
Morphine like agonists
:
Morphine, hydrocodone,
oxycodone, codeine
Mixed Agonist/Antagonists :
Butarphanol, Nalbuphine,
dezocine
Partial Agonist
:
Buprenorphine
www.indiandentalacademy.com
36. The APS, the AHCPR and the AAOMS stipulate an acute
pain management schedule for administration of these agents.
For dental surgery
Behavioural or anxiolytic therapy for disproportionate
anxiety
Oral NSAID’S for simple extraction and
Long acting LA’S and Oral NSAID opioid combinations for
OP control of moderate pain.
Where surgery inhibits oral intake, IV – preferred route.
Transnasal administration of analgesics is another
alternative to oral medications for the control of post operative
pain after O.S.
www.indiandentalacademy.com
37. NSAID’S and OPIODS – Safety and usage concerns in the
differential treatment of postoperative orofacial pain
Post surgical pain can be managed effectively by using
specific treatment methods that are well justified by current
research. These include,
1.
Comprehensive presurgical consultation
2.
Consideration of the use of sedation or GA
3.
Use of Long acting LA
www.indiandentalacademy.com
38. 4.
Administration of an oral analgesics prior to surgery
5.
Meticulous and careful surgery
6.
Administration of perioperative glucocorticoid
7.
Post operative convalescence
8.
A regularly administered analgesic for 48 – 72hours
9.
Consideration of rescue medication
10.
Return for evaluation of unusual or unexpected pain.
www.indiandentalacademy.com
39. ADVANTAGES OF NSAID’S
1.
NSAID’S interfere with the production of prostaglandins
in the surgical wound.
Conversion of arachidonic acid into prostaglandins by
cyclooxygenase is inhibited
Reduction of prostaglandins in the surgical wound results
in a diminished intensity of pain by essentially elevating
the threshold at which pain afferent nerves discharge.
www.indiandentalacademy.com
40. 2.
Effective and useful analgesics for post surgical pain
3.
No risk of addiction and abuse potential
4.
NSAID’S have a topical effect when applied to the
surgical wound and a local effect when injected in or around an
area of wounded tissue.
www.indiandentalacademy.com
41. Risks associated with the use of NSAID’S
Spontaneous GI hemorrhage
Effect on the genito urinary system
Nephrotoxicity
Dyspepsia
Peptic ulcer
Dysphagia
Abdominal pain
Aspirin and NSAID’S have significant risk potential for
severe allergic reactions of anaphylaxis.
www.indiandentalacademy.com
42. Other Potential Adverse Effects
CVS (Tachycardia, edema)
CNS (Dizziness, Headache)
Hepatic (increased liver enzymes) have been reported
Bromfenac sodium was recently with drawn because of
reported cases of fulminant hepatic necrosis.
(JOMS 50; 2004)
www.indiandentalacademy.com
43. Advantages associated with the use of opioids
Opioids have been used as analgesic medications for
centuries, and are the cornerstone for the management of
moderate to severe acute pain.
Opioids have an effect on peripheral sensory nerves
possibility of administering via topical application or local
infusion decrease systemic side effects.
Opioids can be prescribed in combination with NSAID’S
for effective pain management.
www.indiandentalacademy.com
44. Risks associated with opioids
Patient abuse and dependence
Nausea and vomiting
Gastric intolerance
Constipation
Respiratory depressant effect (So contraindicated in
patients with COPD)
Urine retention
CNS (hallucinations, psychomimetic effect)
Hepatic toxicity
www.indiandentalacademy.com
45. Drug Interactions
A number of drug interactions are associated with
analgesics. Many of the interactions occur only after prolonged
use. However it is important to determine if patients are taking
other medications.
www.indiandentalacademy.com
46. Drug Interactions with NSAID’S
DRUG
INTERACTIONS
Antihypertensives (ACE inhibitors, β blockers,
duretics)
Toxicity
Lithium
Toxicity
Methotrexate
Toxicity
Digoxin
Toxicity
Cyclosporine
Toxicity
Anticonvulsants
Toxicity
Anticoagulants
GI Bleeding
Alcohol
GI Bleeding
Acetaminophen / NSAID’s
Nephrotoxicity
www.indiandentalacademy.com
47. Drug Interactions with OPIODS
DRUG
INTERACTIONS
Alcohol
Sedation
Antidiarrheals
Constipation
Antihypertensives
Potentiation of Effect
Barbiturates
Sedation
Carbamazepine
Toxicity
CNS depressants
Sedation
Warfarin
Increased Coagulations
Hypnotics
Sedation
www.indiandentalacademy.com
48. MPDS
It is a functional disorder involving a painful self
perpetuating spasm of the masticatory muscles.
Pre Disposing Factors
•
Stress
•
Clenching and grinding habits
•
Occlusal abnormalities
Muscles found to be commonly involved are
•
Lateral pterygoid and
•
Masseter
www.indiandentalacademy.com
49. TREATMENT
1. Conservative
Limit parafunctional habits
Warm – hot moist compresses
Soft diet
Limit wide opening
NSAID’S
Inf. Of LA into the trigger point of muscles that are in
spasm not containing epinephrine.
Jaw exercises
Opiods
2. Occlusal Splints
3. Biofeed back
4. Nerve Stimulations
www.indiandentalacademy.com
50. TENS
It is an electrical stimulus which is typically generated
from a battery operated device and transmitted to the patient
by electrodes applied to the facial skin.
TENS blocks pain signals being carried over the small
unmyelinated ‘C’ fibers by forming the large myelinated ‘A’
fibers to carry any light touch sensation.
www.indiandentalacademy.com
51. TENS may provide pain relief by the physiologic effects
of rhythmic muscle movements.
The fasiculations of muscles may result in increase in
circulation, decrease in edema and decrease in resting
muscle activity.
Pharmacologic action of TENS may involve the
stimulated release of endorphins which are endogenous
morphine like substances.
www.indiandentalacademy.com
53. The effectiveness of combining analgesic and anxiolytic
agents to control pain and anxiety has been evaluated in a
multicenter, parallel group, double blinded trial involving 997
ambulatory patients undergoing oral surgery with premedication
and LA.
JOMS : Vol.10 – 2000, JOHN. R. ZUNIGA
www.indiandentalacademy.com
54.
Placebo
Midazolam
Midazolam + Midazolam
Midazolam + Fentanyl
Midazolam + Fentanyl + Methohexital
All treatments produced significant reductions in anxiety
levels compared with placebo with Midazolam + Fentanyl +
Methohexital combination being significantly better than others.
www.indiandentalacademy.com
55. Antegrate amnesia was effectively induced and was
significant compared with placebo and MDZ + MDZ and MDZ +
FEN + MHX producing the most significant amnesia.
This study showed that administration of benzodiazipines
led to a desired reduction in anxiety, amnesia and high patient
acceptance.
Greater CNS depression, resulting in better patient
cooperation was achieved by adding an opiod or an opiod plus
a barbiturate.
www.indiandentalacademy.com
56. An open-label evaluation of the efficacy and safety of
Stadol NS with Ibuprofen in the treatment of pain
after removal of Impacted Wisdom Teeth.
JOMS, Vol.10, 2000
-Marvin J, Ladov & Richard K. Stern
Robert wood Johnson University Hospital,
New Brunswick, NJ.
Purpose
This study evaluated the efficacy and safety of
transnasal butarphanol tartrate in the treatment of patients with
moderate to severe pain after oral surgery for the removal of
impacted 3rd molars.
www.indiandentalacademy.com
57. PATIENTS AND METHODS
In this study, 3rd molar extraction was performed on 25
male and 25 female patients. These patients were given Stadol
NS (Nasal Spray), 1mg, administered in a single dose every 4
hours as needed.
Patients were allowed to remedicate 60-
90mts after the initial dose if required. They also took ibuprofen
(400mg) as concomitant medication every 4-6hours for the first
48 hours. Patients recorded pain intensity on a visual analog
scale, with 0 representing no pain, to 100 representing the most
severe pain.
www.indiandentalacademy.com
58. RESULTS
Stadol NS significantly reduced pain (by 50%) after 3rd
molar extraction within 15 minutes after administration. It had
high level of patient acceptance and was well tolerated.
CONCLUSION
The rapid onset of analgesia and long duration of action
shown by Stadol NS in this study, as well as its ease of
administration and high level of patient acceptance, suggest
that this drug would be an excellent primary choice for the
management of pain after 3rd molar extraction and oral surgery
in general.
www.indiandentalacademy.com